Ingevity Corp
$ 74.21
-3.07%
15 Apr - close price
- Market Cap 1,511,470,000 USD
- Current Price $ 74.21
- High / Low $ 76.06 / 73.97
- Stock P/E N/A
- Book Value 6.44
- EPS -9.75
- Next Earning Report 2026-05-06
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.08 %
- ROE -0.88 %
- 52 Week High 51.67
- 52 Week Low 28.49
About
Ingevity Corporation manufactures and sells specialty chemicals and activated carbon materials in North America, Asia-Pacific, Europe, the Middle East, Africa, and South America. The company is headquartered in North Charleston, South Carolina.
Analyst Target Price
$51.75
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-25 | 2025-11-05 | 2025-07-29 | 2025-04-29 | 2025-02-19 | 2024-10-29 | 2024-07-31 | 2024-05-01 | 2024-02-21 | 2023-11-01 | 2023-08-02 | 2023-05-03 |
| Reported EPS | 0.63 | 1.52 | 1.39 | 0.5586 | 0.95 | 1.1 | 1.01 | 0.52 | 0.21 | 1.21 | 1.41 | 1.09 |
| Estimated EPS | 0.6869 | 1.39 | 1.17 | 0.7345 | 0.3075 | 0.9 | 1.05 | 0.32 | -0.19 | 1.22 | 1.37 | 1.13 |
| Surprise | -0.0569 | 0.13 | 0.22 | -0.1759 | 0.6425 | 0.2 | -0.04 | 0.2 | 0.4 | -0.01 | 0.04 | -0.04 |
| Surprise Percentage | -8.2836% | 9.3525% | 18.8034% | -23.9483% | 208.9431% | 22.2222% | -3.8095% | 62.5% | 210.5263% | -0.8197% | 2.9197% | -3.5398% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-06 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | 0.84 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: NGVT
2026-04-16 07:39:12
Ingevity Corporation has announced the sale of its Ozark Materials road markings business to PPG for approximately $65 million, an all-cash transaction that has already closed. This divestiture allows Ingevity to sharpen its strategic focus on its core businesses, while PPG will integrate Ozark Materials into its existing pavement markings solutions. Ingevity plans to update its full-year 2026 financial guidance in conjunction with its first-quarter results to reflect the impact of this transaction.
2026-04-16 02:39:12
Ingevity Corporation has sold its Ozark Materials road markings business to PPG for approximately $65 million in cash, aligning with Ingevity's strategy to focus on its core capabilities while remaining committed to its Pavement Technologies business. This divestiture has been positively received by investors, with Ingevity's shares trading near their 52-week high after a 141% return over the past year. Ingevity plans to update its 2026 financial guidance following this transaction.
2026-04-15 21:39:12
Ingevity announced the cash sale of its Ozark Materials road markings business to PPG Industries for approximately $65 million. This strategic move aims to focus Ingevity's portfolio on its core growth areas, excluding its Pavement Technologies unit. The company is expected to update its 2026 guidance following this transaction.
2026-04-15 20:39:12
Ingevity Corporation has agreed to sell its Ozark Materials road marking business to PPG Industries. This divestiture is part of Ingevity's strategy to optimize its business portfolio and focus on higher-growth core areas. The move aims to enhance the company's operational efficiency and market competitiveness.
2026-04-13 10:10:20
SG Americas Securities LLC reduced its stake in Ingevity Corporation by 61% during the fourth quarter, selling 13,475 shares and retaining 8,615 shares valued at $510,000. This move reflects a shift in the investment firm's strategy amidst volatility in the specialty chemicals sector. The transaction highlights evolving institutional investment approaches in response to market conditions.
2026-04-13 09:10:20
SG Americas Securities LLC significantly reduced its stake in Ingevity Corporation by 61.0% in Q4, selling 13,475 shares and retaining 8,615 shares valued at $510,000. Despite Ingevity missing Q4 earnings estimates, it provided a strong FY2026 EPS guidance of $4.80–$5.20, exceeding analyst forecasts. Institutional investors hold a substantial 91.59% of the stock, with recent large acquisitions from firms like UBS AM and Simcoe Capital Management, while analysts generally rate the stock as a "Hold" with an $80 target price.
